BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25030861)

  • 1. [Dysplastic nodule of liver versus early hepatocellular carcinoma: a clinicopathologic and prognostic study].
    Chen L; Tan Y; Zeng H; Hou Y; Xu J; Zhao J; Ji Y
    Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):301-6. PubMed ID: 25030861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and clinicopathologic significance of GPC3 and other antibodies in well-differentiated hepatocellular carcinoma].
    DU JL; Wei LX; Wang YL
    Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):11-6. PubMed ID: 21429352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.
    Jin GZ; Yu WL; Dong H; Zhou WP; Gu YJ; Yu H; Yu H; Lu XY; Xian ZH; Liu YK; Cong WM; Wu MC
    J Hepatol; 2013 Sep; 59(3):510-7. PubMed ID: 23665285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of glypican-3, hepatocyte antigen, alpha-fetoprotein, CD34 and CD10 in hepatocellular carcinoma: a clinicopathologic analysis of 375 cases].
    Du JL; Wang YL; Shi HY; Guo AT; Wei LX
    Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):309-13. PubMed ID: 22883669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis.
    Di Tommaso L; Franchi G; Park YN; Fiamengo B; Destro A; Morenghi E; Montorsi M; Torzilli G; Tommasini M; Terracciano L; Tornillo L; Vecchione R; Roncalli M
    Hepatology; 2007 Mar; 45(3):725-34. PubMed ID: 17326147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early hepatocellular carcinoma with high-grade atypia in small vaguely nodular lesions.
    Ojima H; Masugi Y; Tsujikawa H; Emoto K; Fujii-Nishimura Y; Hatano M; Kawaida M; Itano O; Kitagawa Y; Sakamoto M
    Cancer Sci; 2016 Apr; 107(4):543-50. PubMed ID: 26797961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.
    Nault JC; Calderaro J; Di Tommaso L; Balabaud C; Zafrani ES; Bioulac-Sage P; Roncalli M; Zucman-Rossi J
    Hepatology; 2014 Dec; 60(6):1983-92. PubMed ID: 25123086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of early hepatocellular carcinoma after hepatic resection.
    Maeda T; Shimada M; Harimoto N; Tsujita E; Aishima S; Tanaka S; Shirabe K; Maehara Y
    Hepatogastroenterology; 2008; 55(85):1428-32. PubMed ID: 18795705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers.
    Witjes CD; ten Kate FJ; Verhoef C; de Man RA; IJzermans JN
    J Clin Pathol; 2013 Aug; 66(8):687-91. PubMed ID: 23585667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging.
    Chou CT; Chou JM; Chang TA; Huang SF; Chen CB; Chen YL; Chen RC
    World J Gastroenterol; 2013 Nov; 19(42):7433-9. PubMed ID: 24259975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognosis of patients with hepatocellular carcinoma of multicentric origin.
    Okusaka T; Okada S; Nose H; Ishii H; Nakasuka H; Nakayama H; Nagahama H; Yoshimori M; Shimada K; Yamamoto J; Takayama T; Kosuge T; Yamasaki S; Sakamoto M; Hirohashi S
    Hepatogastroenterology; 1996; 43(10):919-25. PubMed ID: 8884314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative hepatic resection for hepatocellular carcinoma of cirrhotic patients.
    Sheen PC; Lee KT; Chen HY; Chen JS; Ker CG
    Int Surg; 1996; 81(3):280-3. PubMed ID: 9028990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoexpression of Heat Shock Protein 70, Glypican 3, Glutamine Synthetase, and Beta-Catenin in Hepatocellular Carcinoma After Liver Transplantation: Association Between Positive Glypican 3 and Beta-Catenin With the Presence of Larger Nodules.
    Ataide EC; Perales SR; Silva MG; Filho FC; Sparapani AC; Latuf Filho PF; Stucchi RSB; Vassallo J; Escanhoela CAF; Boin IFSF
    Transplant Proc; 2017 May; 49(4):858-862. PubMed ID: 28457411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronous splenectomy and hepatectomy in patients with hepatocellular carcinoma, hypersplenism and liver cirrhosis.
    Shi R; Zhang YM; Zhu ZJ; Deng YL; Pan C; Zheng H; Shen ZY
    Hepatogastroenterology; 2014; 61(133):1363-7. PubMed ID: 25436312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
    Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
    Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic characteristics of patients with non-B non-C hepatitis virus hepatocellular carcinoma after hepatectomy.
    Kaibori M; Ishizaki M; Matsui K; Kwon AH
    Am J Surg; 2012 Sep; 204(3):300-7. PubMed ID: 22591698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.